Valuation | Industry Range | |
---|---|---|
Price / Earnings | N/A | |
Book Value | 2.84 |   |
Earnings Per Share | -$2.92 |   |
Price To Sales Ratio | 8.11 |   |
Price To Book Ratio | 3.02 |   |
Price To Tangible Book Ratio | 3.07 |   |
Price/Cash Flow Ratio | N/A | |
Price/Free Cash Flow Ratio | N/A |
Profile | Industry Range | |
---|---|---|
Market Capitalization | 366.9M |   |
Float (MRQ) | 78.64% |   |
Shares Outstanding (MRQ) | 48.6M |   |
Short Interest as a % of Float (MRQ) | 2.72% |   |
Shares Held By Institutions (MRQ) | 28.8M |   |
Margins | Industry Range | |
---|---|---|
Sales | $24.5M |   |
Gross Margin | 62.01% |   |
Net Profit Margin | -540.57% |   |
EBIT Margin | -436.23% |   |
EBITDA Margin | -398.24% |   |
Operating Margins | -436.23% |   |
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K
statement or press releases. MRQ = Most Recent Quarter
Financial Strength | Industry Range | |
---|---|---|
Current Ratio (MRQ) | 1.88 |   |
Quick Ratio (MRQ) | 1.88 |   |
Total Debt/Equity Ratio (MRQ) | 101.72 |   |
Debt/Common Equity Ratio (MRQ) | 101.72 |   |
Effectiveness | Industry Range | |
---|---|---|
Return on Equity | -102.81% |   |
Return on Assets | -101.30% |   |
Asset Turnover | 0.19 |   |
Receivables Turnover | 1.10 |   |
Inventory Turnover | N/A |
Earnings and Dividends | Industry Range | |
---|---|---|
EPS Growth Annual | 60.77% |   |
Dividend Yield 5 Year Average | 0.00% |   |
Current Dividend Yield | 0.00% |   |
Current Payout Ratio | N/A |
*MGTX does not pay a dividend. The average dividend yield for companies in the Biotechnology industry is 1.58%